Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2023-04-10 00:00:00 ET · period of report 2023-04-06 · accession 0001735276-23-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-10 | 2023-04-06 | ALNY | Franchini Indrani Lall | EVP, CLO, Sec | S - Sale | $210.00 | -3,500 | 0 | -100% | -$735.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-06 | S | D | 3,500 | $210.00 | 0 | D | — | — |